Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC
• Abstract Triple-negative breast cancer (TNBC) is frequently associated with metastatic relapse, even at an early stage1. • Here we assessed an individualized neoantigen mRNA vacc